Another study on 24 patients with active-progressive MS exhibited that the reduction in EDSS has an intimate association with increased FoxP3+CD4+CD25+ cells and decreased lymphocyte proliferation (Petrou et al., 2021a). The gene discussed is CD4; the disease is myeloid sarcoma.